Pegasys 180mcg Injection
By Pegasys
Rx
10ml Injection in a Vial

Composition
Pegylated Interferon Alpha 2A(180mcg)

Manufacturer - Roche Products India Pvt Ltd
1503, 15th Floor, 'The Capital', Plot no. C-70, Behind ICICI Bank, BKC, Bandra (E) , Mumbai 400051

Expires on or after
August, 2025

liver
Pegasys 180mcg Injection is considered safe for use in patients with liver disease. Based on the available data, it is believed that there may not be a requirement for dose adjustment in these patients. However, it is important to consult with your doctor before using this medication. Regular monitoring of liver function tests is recommended while on treatment with Pegasys 180mcg Injection.

kidney
Pegasys 180mcg Injection requires caution for patients with kidney disease. Adjusting the dosage may be necessary. Consult your doctor for proper guidance.

alcohol
When using Pegasys 180mcg Injection, it is important to be cautious if consuming alcohol. Make sure to consult your doctor regarding alcohol intake with this medication.

driving
Caution Pegasys 180mcg Injection can cause dizziness, confusion, somnolence, and fatigue, affecting driving ability. Patients are advised to avoid driving while using this medication.

pregnancy
Pegasys 180mcg Injection may not be safe to use during pregnancy. Animal studies suggest potential harm to the developing baby. Consult your doctor to assess benefits and risks before use.

breastfeeding
Pegasys 180mcg Injection is considered safe during breastfeeding, as indicated by limited human data showing no significant risk to the baby.
Habit Forming | No |
Chemical Class | Interferons |
Therapeutic Class | - |
Action Class | Interferons |
₹18200
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025